Predicting Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using Machine Learning Models

Predicting Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using Machine Learning Models

Saved in:

Bibliographic Details
Main Authors:	Niharika Dutta, Pankaj Gupta
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:	Indian Journal of Radiology and Imaging
Subjects:	computed tomography deep neural network hepatocellular carcinoma machine learning transarterial chemoembolization treatment response
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809372
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01)

Transarterial chemoembolization in hepatocellular carcinoma treatment during the COVID-19 pandemic
by: Filipović Aleksandar, et al.
Published: (2024-01-01)

Efficacy of cone-beam computed tomography and guidance software in transarterial chemoembolization for hepatocellular carcinoma
by: Shiro Miyayama
Published: (2025-06-01)

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)

Inter-reader agreement of RECIST and mRECIST criteria for assessing response to transarterial chemoembolization in hepatocellular carcinoma
by: Saeed Mohammadzadeh, et al.
Published: (2025-05-01)

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
by: Chengxiang Guo, et al.
Published: (2025-02-01)

Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)

Long‐Term Survival and Prognostic Factors of Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Hoang Dong Duc, et al.
Published: (2025-05-01)

Development and validation of a prealbumin–bilirubin model for prognostic prediction in intermediate hepatocellular carcinoma undergoing transarterial chemoembolization
by: Nan Jiang, et al.
Published: (2025-05-01)

Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients
by: Yunjie Zhang, et al.
Published: (2025-07-01)

Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma
by: Wei Fan Sui, et al.
Published: (2025-06-01)

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
by: Reham Ashour, et al.
Published: (2024-11-01)

Defining a radiomics feature selection method for predicting response to transarterial chemoembolization in hepatocellular carcinoma patients
by: Helen Zhang, et al.
Published: (2024-03-01)

Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria
by: Sodai Hoshiai, et al.
Published: (2025-05-01)

Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
by: S. A. Ivanov, et al.
Published: (2023-03-01)

Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial
by: Xue-Feng Kan, et al.
Published: (2025-05-01)

Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma
by: Alhaddad Omkolsoum, et al.
Published: (2024-12-01)

Balloon-occluded versus conventional transarterial chemoembolization for the treatment of early to intermediate stage hepatocellular carcinoma: a meta-analysis and trial sequential analysis
by: Jiaxi Liu, et al.
Published: (2025-07-01)

Transarterial chemoembolization with 125I seed insertion for unresectable hepatocellular carcinoma: a meta‑analysis
by: Rui Zhu, et al.
Published: (2025-03-01)

Radiomic features at contrast-enhanced CT predict proliferative hepatocellular carcinoma and its prognosis after transarterial chemoembolization
by: Haifeng He, et al.
Published: (2025-03-01)

Transarterial chemoembolization for advanced hepatocellular carcinoma after failure of first-line systemic treatment: a single-center case series
by: Qingyu Xu, et al.
Published: (2025-08-01)

Drug-eluting beads transarterial chemoembolization vs conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma in adult patients: a systematic review and update meta-analysis of observational studies
by: Tatiana Chernyshenko, et al.
Published: (2025-02-01)

Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
by: Edoardo Poli, et al.
Published: (2025-02-01)

Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
by: Meng Zhao, et al.
Published: (2025-02-01)

Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01)

Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta‐Analysis
by: Wenjie Li, et al.
Published: (2025-07-01)

Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90
by: Kathryn Bress, et al.
Published: (2025-04-01)

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)
by: Hang Yuan, et al.
Published: (2025-07-01)

The predictive value of PIV, PLR, LMR, NPR, and NLR for the prognosis of transarterial chemoembolization in patients with hepatocellular carcinoma combined with liver cirrhosis
by: Yanan Wei, et al.
Published: (2025-04-01)

Feasibility, efficacy, and safety of ventral caudal artery access for transarterial chemoembolization in a rat hepatocellular carcinoma model
by: Wei Hong, et al.
Published: (2025-07-01)

Idarubicin-loaded drug-eluting microspheres transarterial chemoembolization for intermediate stage hepatocellular carcinoma: safety, efficacy, and pharmacokinetics
by: Korsic Spela, et al.
Published: (2024-10-01)

Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma
by: Shaobo Zhang, et al.
Published: (2025-05-01)

Comparison of liver injury and inflammatory response following conventional and drug-eluting bead transcatheter chemoembolization in hepatocellular carcinoma
by: Ran You, et al.
Published: (2025-04-01)

Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma
by: Shengyuan Xu, et al.
Published: (2025-05-01)

Prophylactic transarterial chemoembolization after R0 resection is beneficial to improve the prognosis in hepatocellular carcinoma patients with microvascular invasion
by: Wenjie Sun, et al.
Published: (2025-06-01)

Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-12-01)

Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors
by: Chen W, et al.
Published: (2025-02-01)

Identification of transarterial chemoembolization candidates in advanced hepatocellular carcinoma patients classified solely by performance status 1: a multicenter retrospective study
by: Jing Li, et al.
Published: (2025-05-01)